Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 26.05
-0.25 (-0.95%)
May 8, 2026, 1:30 PM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 5.81 billion as of May 8, 2026. Its market cap has decreased by -12.88% in one year.
Market Cap
5.81B
Enterprise Value
5.38B
Revenue
1.40B
Ranking
n/a
PE Ratio
28.80
Stock Price
26.05
Market Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 5.81B, an increase of 41.16%. That is a compound annual growth rate of 2.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 5.81B | -0.38% |
| Dec 31, 2025 | 5.83B | -27.36% |
| Dec 31, 2024 | 8.03B | 80.00% |
| Dec 29, 2023 | 4.46B | 14.13% |
| Dec 30, 2022 | 3.91B | 11.76% |
| Dec 30, 2021 | 3.50B | 28.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Handa Pharmaceuticals | 11.70B |
| Standard Chemical & Pharmaceutical | 10.95B |
| Alar Pharmaceuticals | 9.39B |
| Formosa Laboratories | 6.59B |
| LIWANLI Innovation | 6.09B |
| SCI Pharmtech | 5.65B |
| Easywell Biomedicals | 4.51B |
| Orient EuroPharma | 4.04B |